跳至主要内容
临床试验/CTRI/2025/05/086306
CTRI/2025/05/086306尚未招募不适用

To evaluate the in vivo safety and efficacy of skin care formulations in terms of reduction in acne on healthy human subjects

Doctor Safe Towel Factory Private Limited.1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2025年5月13日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
66
试验地点
1
主要终点
Reduction in acne

研究概览

简要总结

OBJECTIVE-The objective of this study will be to evaluate the in-vivo safety and efficacyof a skin care formulation in terms of reduction in acne on healthy human subjectsThe evaluation is performed using- Subject Self Evaluation(SSE)           , Dermatological Evaluation:Cosmetic Acceptability, Dermatological Evaluation: Efficacy, Images of whole face under Diffused Light

POPULATION-66 female & male subjects will be selected for the study. The study will beconducted in 2 groups and 33 subjects in each group.Group A - Product A

Group B - Product B

The subjects selected for this study are healthymale and female, aged between 18 and 30 years,presenting mild to moderateacne and oily to mixed oily skin type.

 STUDY DURATION-14 days following the first  use of the product.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 30.00 Year(s)(—)
性别
All

入选标准

  • 1.Indian Male and Female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) 4.Having mild to moderate acne.
  • 5.Having mixed oily or oily skin type.

排除标准

  • for female-Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • Having refused to give his/her assent by not signing the consent form and Informed consent form
  • Taking part in another study liable to interfere with this study
  • Being known diabetic case
  • Known asthma case
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
  • Being known thyroid case
  • Being epileptic.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
  • Known case of hypersensitivity.
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

结局指标

主要结局

Reduction in acne

时间窗: Baseline , Day 14

次要结局

未报告次要终点

研究者

发起方
Doctor Safe Towel Factory Private Limited.
申办方类型
Other [Non-government company ]

研究点 (1)

Loading locations...

相似试验